Star Foot & Ankle Specialists Pllc | |
3550 Parkwood Blvd Ste 702, Frisco, TX 75034-1920 | |
(972) 559-0051 | |
Not Available |
Full Name | Star Foot & Ankle Specialists Pllc |
---|---|
Type | Facility |
Speciality | Podiatrist |
Location | 3550 Parkwood Blvd Ste 702, Frisco, Texas |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356013486 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | (* (Not Available)) | Primary |
Provider Name | Gary A Heredia |
---|---|
Provider Type | Practitioner - Podiatry |
Provider Identifiers | NPI Number: 1508270695 PECOS PAC ID: 7113147281 Enrollment ID: I20170705000657 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.
In most cases (61%) a diagnosis was possible after two passes with the biopsy needle. There were no major complications. In 14 of the patients, malignancy was diagnosed; eight patients had benign results.
UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.
› Verified 8 days ago
Provider Name | Morgan Z Kaplan |
---|---|
Provider Type | Practitioner - Podiatry |
Provider Identifiers | NPI Number: 1952716078 PECOS PAC ID: 8325331945 Enrollment ID: I20211105001249 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.
In most cases (61%) a diagnosis was possible after two passes with the biopsy needle. There were no major complications. In 14 of the patients, malignancy was diagnosed; eight patients had benign results.
UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Star Foot & Ankle Specialists Pllc 3550 Parkwood Blvd Ste 702, Frisco, TX 75034-1920 Ph: () - | Star Foot & Ankle Specialists Pllc 3550 Parkwood Blvd Ste 702, Frisco, TX 75034-1920 Ph: (972) 559-0051 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.
In most cases (61%) a diagnosis was possible after two passes with the biopsy needle. There were no major complications. In 14 of the patients, malignancy was diagnosed; eight patients had benign results.
UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.
› Verified 8 days ago
Dr. Thomas Huu Tran, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7533 Trailway Drive, Frisco, TX 75035 Phone: 972-335-9071 Fax: 972-335-8920 | |
Southwestern Foot & Ankle Associates, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3880 Parkwood Blvd, Suite 602, Frisco, TX 75034 Phone: 972-335-9071 Fax: 972-335-8920 | |
Texas Family Footcare Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5575 Warren Pkwy, Suite 101, Frisco, TX 75034 Phone: 972-712-4161 Fax: 972-412-4289 | |
Stonebriar Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 5575 Warren Pkwy Ste 101, Frisco, TX 75034 Phone: 972-712-4161 Fax: 972-712-4289 | |
Jaskern Dhami, Podiatrist Medicare: Medicare Enrolled Practice Location: 5375 Coit Rd Ste 100, Frisco, TX 75035 Phone: 972-712-7773 | |
Footcare, P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9300 John Hickman Pkwy Ste 1304, Frisco, TX 75035 Phone: 972-939-1757 Fax: 972-939-1682 | |
Premier Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 9359 Legacy Dr Ste 300b, Frisco, TX 75033 Phone: 217-473-5877 Fax: 972-270-7759 |